Results 151 to 160 of about 174,614 (242)

Observational study on the efficacy and safety of FOLFOXIRI therapy for locally advanced rectal cancer: The Kanagawa Yokohama Colorectal Cancer Study Group (KYCC)1802. [PDF]

Int J Colorectal Dis
Okamoto H, Sugano N, Sato M, Iguchi K, Asari M, Kazama K, Numata M, Godai T, Higuchi A, Mushiake H, Saito A, Shiozawa M.   +11 more
europepmc   +1 more source

Neoadjuvant Chemotherapy With Chemoradiotherapy for Patients With Borderline Resectable or Locally Advanced Pancreatic Ductal Adenocarcinoma— Retrospective Review From a Tertiary Care Hospital

Asia-Pacific Journal of Clinical Oncology, EarlyView.
A single‐centre retrospectively analyzed 37 BRPC/LAPC patients receiving neoadjuvant chemotherapy ± chemoradiotherapy. Surgical resection was feasible in 62% of patients, with 38% of patients achieving R0 resections. The median overall survival was 21 months, and disease‐free survival was 12.7 months.
Avtaj Nerwal, Desmond Yip, Sivakumar Gananadha, Amy Shorthouse, Belinda Lee, Ankit Jain   +5 more
wiley   +1 more source

Complete response of advanced esophageal squamous cell carcinoma with first-line chemotherapy combined with immunotherapy: a Case report. [PDF]

Front Immunol
Wei Y, Han S, Shi Y, Li Y, Zhang Q, Zhang L, Cheng Y, Yan X, Jia Y.   +8 more
europepmc   +1 more source

CDX2 Promoter‐Controlled Oncolytic Adenovirus Suppresses Tumor Growth and Liver Metastasis of Colorectal Cancer

Cancer Science, EarlyView.
CDX2 promoter‐controlled oncolytic adenovirus attenuates CDX2‐positive colorectal cancer liver metastasis growth in a mouse model. ABSTRACT Colorectal cancer (CRC) is the second leading cause of cancer death worldwide, and liver metastasis (CRLM) is the most common among its distant metastases.
Naohiko Nakamura, Mizuho Sato‐Dahlman, Elise Travis, Kari Jacobsen, Masato Yamamoto   +4 more
wiley   +1 more source

RETRACTION: Effect of Mitomycin C and 5-Fluorouracil on Wound Healing in Patients Undergoing Glaucoma Surgery: A Meta-Analysis. [PDF]

Int Wound J
europepmc   +1 more source

Potential effects of adenosine triphosphate and melatonin on oxidative and inflammatory optic nerve damage in rats caused by 5-fluorouracil. [PDF]

Int J Ophthalmol
Somuncu AM, Parlak Somuncu B, Ozbay AD, Cicek I, Suleyman B, Mammadov R, Bulut S, Bal Tastan T, Coban TA, Suleyman H, Aydin A.   +10 more
europepmc   +1 more source

The C11orf24 Gene as a Useful Biomarker for Predicting Severe Neutropenia in Modified FOLFIRINOX for Pancreatic Cancer

Cancer Science, EarlyView.
FOLFIRINOX improves the prognosis of patients with pancreatic cancer; however, despite UGT1A1 screening, adverse events, such as severe neutropenia, occur frequently. The diagnostic performance of the neutropenia prediction model showed areas under the curve of 0.754 (sensitivity=0.605, specificity=0.848) and 0.856 (sensitivity=0.800, specificity=0.893)
Gen Kanesada, Ryouichi Tsunedomi, Yuki Nakagami, Hiroto Matsui, Yoshitaro Shindo, Shinobu Tomochika, Hirofumi Akita, Tatsuya Ioka, Hidenori Takahashi, Hiroaki Nagano   +9 more
wiley   +1 more source

GEMPAX, do we have another second-line option after mFOLFIRINOX in pancreatic cancer? [PDF]

Ann Transl Med
Boyle K, Perez KJ.
europepmc   +1 more source

Polo‐Like Kinase 1 Expression in Colorectal Cancer: Association With RAS Mutations

Cancer Science, EarlyView.
PLK1 expression may serve as a biomarker for adjuvant chemotherapy resistance in CRC. This study focused on the relationship between PLK1 expression and RAS mutation, which has been reported to be highly sensitive to PLK1 inhibitors. RAS mutation with high PLK1 expression predicts poorer survival in adjuvant‐treated CRC patients.
Yasushi Tanaka, Eiji Oki, Ryota Nakanishi, Tetsuro Kawazoe, Kensuke Kudo, Yoko Zaitsu, Yuichi Hisamatsu, Koji Ando, Yoshinao Oda, Tomoharu Yoshizumi   +9 more
wiley   +1 more source

The current landscape of gastric cancer and gastroesophageal junction cancer diagnosis and treatment in China: a comprehensive nationwide cohort analysis. [PDF]

J Hematol Oncol
Chen Y, Jia K, Xie Y, Yuan J, Liu D, Jiang L, Peng H, Zhong J, Li J, Zhang X, Shen L.   +10 more
europepmc   +1 more source